News & Resources
At Xinsider Capital, we keep close tabs on the investment industry and startup ecosystems. Check out these articles to learn more about the companies we are working with. If you’d like more information about our partners or our line of work, get in touch directly.
Mergers & Acquisitions Roundup
Deep Medicine Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
Mergers & Acquisitions Roundup
NEW YORK, NY / ACCESSWIRE / December 9, 2021 /Â Jupiter Wellness Acquisition Corp. (Nasdaq:JWACU) (the "Company") today announced the closing of its upsized initial public offering of 13,800,000 units at a price to the public of $10.00 per unit, which includes 1,800,000 units issued pursuant to the underwriters' exercise of the over-allotment option in full, with the offering raising gross proceeds of $138,000,000. The units commenced trading on Tuesday, December 7, 2021, on The Nasdaq Global Market ("Nasdaq") under the symbol "JWACU." Each unit issued in the initial public offering consists of one share of Class A common stock and one right to receive one-eighth of one share of Class A common stock upon the consummation of the Company's initial business combination. Once the securities comprising the units begin separate trading, the shares of Class A common stock and rights are expected to be listed on Nasdaq under the symbols "JWACQ" and "JWACR," respectively.
I-Bankers Securities, Inc. acted as sole book-running manager of the offering.
Of the proceeds received from the consummation of the initial public offering and a simultaneous private placement of units, $139,380,000 (or $10.10 per unit sold in the public offering) was placed in trust. An audited balance sheet of the Company as of December 9, 2021 reflecting receipt of the proceeds upon consummation of the initial public offering and the private placement will be included as an exhibit to a Current Report on Form 8-K to be filed by the Company with the Securities and Exchange Commission (the "SEC").
